The incidence and prevalence of multiple sclerosis in Nova Scotia, Canada

Canadian Journal of Neurological Sciences

Volumn 40, Issue 6, 2013, Pages 824-831

  Marrie, Ruth Ann ^a,b   Fisk, John D ^c,d   Stadnyk, Karen J ^d   Yu, Bo Nancy ^a,b   Tremlett, Helen ^e   Wolfson, Christina ^f,g   Warren, Sharon ^h   Bhan, Virender ^c,d  

^a UNIVERSITY OF MANITOBA   (Canada)

^b HEALTH SCIENCES CENTRE   (Canada)

^c DALHOUSIE UNIVERSITY   (Canada)

^d Capital District Health Authority   (Canada)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^f Department of Epidemiology and Biostatistics and Occupational Health ^*  (Canada)

^g RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^h UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANADA; FEMALE; GROUPS BY AGE; HEALTH SURVEY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; FACTUAL DATABASE; NOVA SCOTIA;

DATABASES, FACTUAL; HUMANS; INCIDENCE; MULTIPLE SCLEROSIS; NOVA SCOTIA; PREVALENCE;

EID: 84888254346     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100015961     Document Type: Article

References (26)

1. Evans C, Beland S, Kulaga S, et al. Incidence and prevalence of multiple sclerosis in the Americas: a systematic review. Neuroepidemiology. 2013;40(3):195-210.
2. Allison RS. Geographic distribution of multiple sclerosis. Preliminary notes on a comparative study of prevalence in Charleston, S.C. and Halifax, N.S. Acta Psychiatrica Scandinavica Suppl. 1960;35(147):18-22.
3. Alter M, Talbert OR, Allison RS, Kurland LT. The geographic distribution of multiple sclerosis. A comparative study in Charleston County, South Carolina and Halifax County, Nova Scotia. I. Prevalence in Charleston County, South Carolina. J S C Med Assoc. 1960;56:209-13.
4. Patten S. Integrating data from clinical and administrative databases in pharmacoepidemiological research. Can J Clin Pharmacol. 1998;5(2):92-7.
5. Marrie RA, Yu N, Blanchard JF, Leung S, Elliott L. The rising prevalence and changing age distribution of multiple sclerosis in Manitoba. Neurology. 2010;74(6):465-71.
6. Canadian Institute for Health Information. Physicians in Canada: The status of Alternative Payment Programs 2005-2006. Ottawa: CIHI; 2008.
7. Sketris I, Hicks V, Brown MJ, et al. Multiple sclerosis diseasemodifying drug utilization patterns following introduction of a provincially funded program in Nova Scotia, Canada, 1998-2004. J Appl Ther Res. 2011;8(2):65-78.
8. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol. 2005;58(6):840-6.
9. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001;50(1):121-7.
10. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol. 1983;13(3):227-31.
11. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria. Ann Neurol. 2011;69(2):292-302.
12. Youden WJ. Index for rating diagnostic tests. Cancer. 1950:32-5.
13. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159-74.
14. Miller DH, Chard DT, Ciccarelli O. Clinically isolated syndromes. Lancet Neurol. 2012;11(2):157-69.
15. Beck CA, Metz LM, Svenson LW, Patten SB. Regional variation of multiple sclerosis prevalence in Canada. Mult Scler. 2005;11(5): 516-9.
16. Hader WJ, Yee IML. Incidence and prevalence of multiple sclerosis in Saskatoon, Saskatchewan. Neurology. 2007;69(12):1224-9.
17. Marrie R, Yu B, Leung S, et al. Rising prevalence of vascular comorbidities in MS: validation of administrative definitions for diabetes, hypertension, hyperlipidemia. Mult Scler. 2012;18(9):1310-9.
18. Warren SA, Svenson LW, Warren KG. Contribution of incidence to increasing prevalence of multiple sclerosis in Alberta, Canada. Mult Scler. 2008;14(7):872-9.
19. Fromont A, Binquet C, Sauleau E, et al. National estimate of multiple sclerosis incidence in France (2001-2007). Mult Scler. 2012;18(8):1108-15.
20. Modrego PJ, Pina MA. Trends in prevalence and incidence of multiple sclerosis. J Neurol Sci. 2003;216:89-93.
21. Sloka JS, Pryse-Phillips WEM, Stefanelli M. Incidence and prevalence of multiple sclerosis in Newfoundland and Labrador. Can J Neurol Sci. 2005;32:37-42.
22. Alonso A, Hernan MA. Temporal trends in the incidence of multiple sclerosis: A systematic review. Neurology. 2008;71(2): 129-35.
23. Bostrom I, Stawiarz L, Landtblom A-M. Sex ratio of multiple sclerosis in the National Swedish MS Register. Mult Scler. 2013; 19(1):46-52.
24. Culpepper WJ, Ehrmantraut M, Wallin MT, Flannery K, Bradham DD. Veterans Health Administration multiple sclerosis surveillance registry: The problem of case-finding from administrative databases. J Rehabil Res Dev. 2006;43(1):17.
25. Theou O, Rockwood MR, Mitnitski A, Rockwood K. Disability and co-morbidity in relation to frailty: how much do they overlap Arch Gerontol Geriatr. 2012;55(2):e1-8.
26. Ploughman M, Austin MW, Murdoch M, et al. Factors influencing healthy aging with multiple sclerosis: a qualitative study. Disabil Rehabil. 2012;34(1):26-33.